Menu Back to Event-Details

Patient Preference Studies in Regulatory Decisions: Opportunities and Challenges

Track:
Hot Topic/Stand Alone

Day & Time:
April 17, 9:00AM - 10:30AM (Central Europe Standard Time)

Session Number:
SAT2

Type:
Session

Title:
IMI PREFER: Patient Perspective in Benefit-Risk Assessments during the Medical Product Life Cycle

Chair(s):
Conny Berlin, MS
Global Head, Quantitative Safety and Epidemiology
Novartis Pharma AG, Switzerland

Description:
Patient involvement in development of medicinal products is a topic rapidly evolving. However, how can patient preferences be elicited? Can it be used for regulatory decision making about benefits and risks of medicinal products? This session presents expectations, needs and concerns of different stakeholders and promising approaches how to address these.

Presentation(s) & Speaker(s):
Patient Preference Studies in Regulatory Decisions: Opportunities and Challenges
Sabine Haubenreisser, PhD, MSc
Principal Scientific Administrator, International Affairs
European Medicines Agency (EMA), United Kingdom

Exploring and Eliciting Patient Preferences: Why, When and How
Esther De Bekker-Grob
Associate Professor of Health Economics & Health Preferences, Erasmus School of
Erasmus University Rotterdam, Netherlands

Patients as Collaborators in Research
Isabelle Manneh-Vangramberen
Projects Coordinator
European Cancer Patient Coalition (ECPC), Belgium